Report ID: 10086181 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
"It is expected that during the forecast period, the compound annual growth rate of the global vascular access equipment market will be close to 5% between 2022-2030. In the past decade, the prevalence of several chronic diseases requiring vascular access treatment has increased. Some major chronic diseases include cancer, kidney failure and heart disease. In addition, there are lifestyle disorders related to chronic and non-communicable diseases, such as high blood pressure, diabetes, obesity, and depression, which require intensive care during your hospital stay. ESRD) continues to increase at a significant rate worldwide, leading to chronic kidney disease (CKD). In 2017, approximately 30 million people in the United States (15% of American adults) had chronic kidney disease (CKD). CKD was found to be more common in women (16%) than in men (13%).
For patients undergoing dialysis, the ideal method of vascular access is through arteriovenous fistula (ANF) and consult a nephrologist about alternative treatments. In the case of chemotherapy, vascular access catheter devices are also used extensively. According to data from the Centers for Disease Control and Prevention (CDC), in the United States, approximately 650,000 cancer patients receive chemotherapy in cancer clinics each year. With the increasing prevalence of chronic diseases and lifestyle disorders, vascular access surgery is increasingly used for intravenous antibiotic therapy, prolonged intravenous nutritional support and blood sampling. Therefore, this is expected to attract the attention of many multinational medical device companies to invest and launch new products, thus becoming one of the main driving forces of the market.
REPORTING SCOPE:
According to the reporting scope, vascular access devices (VAD) are inserted into veins for diagnostic and therapeutic reasons, such as blood sampling, central venous pressure readings, administration, fluids, total parenteral nutrition (TPN), and blood transfusions.
These are inserted from the periphery or the center. Each patient has different equipment choices, and multiple types of equipment may be required at the same time, because a single device may not meet all requirements.
MAIN MARKET TRENDS:
Drug management is expected to occupy a larger share in the application field. The drug management field is estimated to account for the largest share of the market, because the growth in the drug management field is attributed to the large number of vascular access devices for drug delivery to treat infections, cancers and other diseases .
Catheters have multiple functions, including specialized treatments such as drug delivery, blood draw, and hemodialysis. The vascular access catheter can be inserted into the periphery or center of the patients arm, such as the patient;s jugular vein.
DURING THE FORECAST PERIOD , NORTH AMERICA WILL DOMINATE THE VASCULAR ACCESS EQUIPMENT MARKET:
North America is expected to account for the majority of the market, mainly due to the high prevalence of cardiovascular diseases in the United States. The number of cancer cases has increased; and the research and clinical trials of vascular access devices have increased. In addition, in a large number of cases of end-stage renal disease (ESRD), dialysis patients receive catheterization and are performed in outpatient clinics. Therefore, by allowing the following operations to be performed, the inpatient non-emergency interventional procedures for ESRD patients are reduced. Factors such as the governments regulatory guidelines for medical device companies and better healthcare infrastructure play a key role in the business growth and new product launches of multinational companies, thus contributing to the market. Increase.
COMPETITIVE LANDSCAPE:
The vascular access equipment market is fiercely competitive, with small and medium-sized enterprises competing for market share. However, some companies that have performed well in the market are B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, NIPRO Medical Corporation and Fresenius Medical Care."
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10086181 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
